InfuCare Rx Acquires FOSRx Fast Pharmacy In Strategic Transaction

Wednesday, December 12, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

InfuCare Rx Creates National Home Infusion and Specialty Pharmacy Platform

ASTON, Pa., Dec. 12, 2018 /PRNewswire-PRWeb/ -- InfuCare Rx announces the strategic acquisition of Factor One Source

Fast Pharmacy. Factor One Source Fast Pharmacy is a specialty pharmacy providing medications and services to people with complex or hard-to-manage medications.

Headquartered in Cumberland, Maryland, with branch locations in Louisiana and Texas, Factor One Source Fast Pharmacy is able to serve patients in all 50 United States. The pharmacies dispense specialized medications for conditions related to hemophilia, rheumatology, dermatology, immunoglobulin therapy and gastroenterology.

Factor One Source Fast Pharmacy will be a wholly owned subsidiary of InfuCare Rx and will continue to operate under the same name with similar goals. The combined company will now operate from 5 locations in Maryland, New Jersey, Pennsylvania, Louisiana, and Texas. The transaction strengthens InfuCare's market presence nationally and will leverage existing relationships with providers, payors, and a growing patient base.

Dr. Roy has driven the growth of Factor One Source Fast Pharmacy including the prior acquisition of Louisiana based, Fast Access Specialty Therapeutics which was announced in 2017. Dr. Roy is a former Commissioner on the Maryland Board of Pharmacy and National Association of Boards of Pharmacy and a quadruple board-certified pharmacist (PharmD, CGP, CACP, CPSO, CSP). Dr. Sajal Roy will continue with the Company and serve as Vice President of Operations.

"One of the long-term goals of Factor One Source/FAST Pharmacy has always been to add home infusion services to our specialty pharmacy platform. Through this strategic transaction, our combination establishes a robust platform for our continued growth." stated Dr. Roy.

"FOSRx Fast is a strong fit with InfuCare's strategic focus to integrate and expand its home infusion services for immunoglobulin therapy, hemophilia, and parenteral nutrition along with adding other specialty pharmacy initiatives. This acquisition drives significant operating synergies and enables us to maximize our clinical focus and expand our market reach nationally." said Deven Patel, CEO of InfuCare Rx.

Terms of the transaction were not disclosed. Paragon Ventures acted at the exclusive advisor to Factor One Source Fast Pharmacy. The transaction team was led by Jonathan Sadock, Managing Partner/CEO of Paragon Ventures.

About InfuCare Rx InfuCare Rx is a leading home infusion and specialty pharmacy provider with locations in Pennsylvania and New Jersey. InfuCare Rx is URAC Specialty and ACHC accredited and noted for its clinical and reimbursement expertise working for patients with chronic conditions. InfuCare's clinical team has over 30 years of experience managing patients in their home and alternate site settings. http://www.infucarerx.com

About FOSRx/FAST Factor One Source Fast Pharmacy is a triple accredited specialty pharmacy headquartered in Cumberland, Maryland. The Company was founded in 2010 and offers medicine delivery for specialty conditions to patients in their home, hospital, physician's office, or infusion center. The pharmacy works for patients with complex or hard-to-manage medications and focuses on clinical experience and support of patients in rheumatology, dermatology, hematology, oncology, addiction recovery, and osteoporosis among others. http://www.fosrx.com

About Paragon Ventures Paragon Ventures is a leading specialist in strategic transactions including the merger and acquisition of private mid-market healthcare companies. Celebrating its 25th year in business, Paragon Ventures has advised thousands of healthcare business owners and successfully closed over 225 strategic healthcare transactions. http://www.paragonventures.com 800-719-1555 Ext 201

 

SOURCE Paragon Ventures



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store